Methylation of RASSF1A gene promoter is regulated by p53 and DAXX

FASEB Journal

Volumn 27, Issue 1, 2013, Pages 232-242

  Zhang, Hailong ^a   He, Jing ^a   Li, Jiansha ^a   Tian, Dan ^a   Gu, Lubing ^a   Zhou, Muxiang ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute lymphoid leukemia; Epigenetic gene silencing; Protein DNA binding

Indexed keywords

DAXX PROTEIN; DNA METHYLTRANSFERASE 1; PROTEIN MDM2; PROTEIN P53; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA METHYLATION; GEL MOBILITY SHIFT ASSAY; IN VITRO STUDY; LEUKEMIA CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN METHYLATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WILD TYPE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BASE SEQUENCE; CELL LINE, TUMOR; DNA; DNA METHYLATION; DNA PRIMERS; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

MURINAE;

EID: 84871899081     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-215491     Document Type: Article

References (43)

1. Donninger, H., Vos, M. D., and Clark, G. J. (2007) The RASSF1A tumor suppressor. J. Cell Sci. 120, 3163-3172 (Pubitemid 350018407)
2. Van der Weyden, L., and Adams, D. J. (2007) The Ras-association domain family (RASSF) members and their role in human tumourigenesis. Biochim. Biophys. Acta 1776, 58-85
3. Song, M. S., Song, S. J., Kim, S. Y., Oh, H. J., and Lim, D. S. (2008) The tumour suppressor RASSF1A promotes MDM2 self-ubiquitination by disrupting the MDM2-DAXX-HAUSP complex. EMBO J. 27, 1863-1874
4. Richter, A. M., Pfeifer, G. P., and Dammann, R. H. (2009) The RASSF proteins in cancer: from epigenetic silencing to functional characterization. Biochim. Biophys. Acta 1796, 114-128
5. Dammann, R., Li, C., Yoon, J. H., Chin, P. L., Bates, S., and Pfeifer, G. P. (2000) Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat. Genet. 25, 315-319 (Pubitemid 30437320)
6. Pfeifer, G. P., Yoon, J. H., Liu, L., Tommasi, S., Wilczynski, S. P., and Dammann, R. (2002) Methylation of the RASSF1A gene in human cancers. Biol. Chem. 383, 907-914 (Pubitemid 34874094)
7. Levine, A. J. (1997) p53, the cellular gatekeeper for growth and division. Cell 88, 323-331
8. Miyashita, T., and Reed, J. C. (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293-299
9. Takimoto, R., and El-Deiry, W. S. (2000) Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequencespecific DNA-binding site. Oncogene 19, 1735-1743 (Pubitemid 30200979)
10. Owen-Schaub, L. B., Zhang, W., Cusack, J. C., Angelo, L. S., Santee, S. M., Fujiwara, T., Roth, J. A., Deisseroth, A. B., Zhang, W. W., and Kruzel, E. (1995) Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol. Cell. Biol. 15, 3032-3040
11. Zastawny, R. L., Salvino, R., Chen, J., Benchimol, S., and Ling, V. (1993) The core promoter region of the P-glycoprotein gene is sufficient to confer differential responsiveness to wild-type and mutant p53. Oncogene 8, 1529-1535 (Pubitemid 23189049)
12. Miyashita, T., Harigai, M., Hanada, M., and Reed, J. C. (1994) Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res. 54, 3131-3135 (Pubitemid 24208916)
13. Hoffman, W. H., Biade, S., Zilfou, J. T., Chen, J., and Murphy, M. (2002) Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J. Biol. Chem. 277, 3247-3257 (Pubitemid 34953189)
14. Mirza, A., Wu, Q., Wang, L., McClanahan, T., Bishop, W. R., Gheyas, F., Ding, W., Hutchins, B., Hockenberry, T., Kirschmeier, P., Greene, J. R., and Liu, S. (2003) Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression. Oncogene 22, 3645-3654 (Pubitemid 36765324)
15. Kern, S. E., Kinzler, K. W., Bruskin, A., Jarosz, D., Friedman, P., Prives, C., and Vogelstein, B. (1991) Identification of p53 as a sequence-specific DNA-binding protein. Science 252, 1708-1711 (Pubitemid 21917093)
16. Esteve, P. O., Chin, H. G., and Pradhan, S. (2005) Human maintenance DNA (cytosine-5)-methyltransferase and p53 modulate expression of p53-repressed promoters. Proc. Natl. Acad. Sci. U. S. A. 102, 1000-1005 (Pubitemid 40170715)
17. Yang, X., Khosravi-Far, R., Chang, H. Y., and Baltimore, D. (1997) Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 89, 1067-1076 (Pubitemid 127678740)
18. Torii, S., Egan, D. A., Evans, R. A., and Reed, J. C. (1999) Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs). EMBO J. 18, 6037-6049 (Pubitemid 29515680)
19. Chang, H. Y., Nishitoh, H., Yang, X., Ichijo, H., and Baltimore, D. (1998) Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx. Science 281, 1860-1863 (Pubitemid 28450508)
20. Tang, J., Qu, L. K., Zhang, J., Wang, W., Michaelson, J. S., Degenhardt, Y. Y., El-Deiry, W. S., and Yang, X. (2006) Critical role for Daxx in regulating Mdm2. Nat. Cell Biol. 8, 855-862 (Pubitemid 44151589)
21. Huang, Y. S., and Shih, H. M. (2009) Daxx positively modulates beta-catenin/TCF4-mediated transcriptional potential. Biochem. Biophys. Res. Commun. 386, 762-768
22. Croxton, R., Puto, L. A., de Belle, I., Thomas, M., Torii, S., Hanaii, F., Cuddy, M., and Reed, J. C. (2006) Daxx represses expression of a subset of antiapoptotic genes regulated by nuclear factor-kappaB. Cancer Res. 66, 9026-9035 (Pubitemid 44521121)
23. Wethkamp, N., and Klempnauer, K. H. (2009) Daxx is a transcriptional repressor of CCAAT/enhancer-binding protein beta. J. Biol. Chem. 284, 28783-28794
24. Puto, L. A., and Reed, J. C. (2008) Daxx represses RelB target promoters via DNA methyltransferase recruitment and DNA hypermethylation. Genes Dev. 22, 998-1010 (Pubitemid 351544239)
25. Zhou, M., Yeager, A. M., Smith, S. D., and Findley, H. W. (1995) Overexpression of the MDM2 gene by childhood acute lymphoblastic leukemia cells expressing the wild-type p53 gene. Blood 85, 1608-1614
26. Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D., and Baylin, S. B. (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. U. S. A. 93, 9821-9826 (Pubitemid 26296693)
27. Gu, L., Zhu, N., Zhang, H., Durden, D. L., Feng, Y., and Zhou, M. (2009) Regulation of XIAP translation and induction by MDM2 following irradiation. Cancer Cell 15, 363-375
28. Gostissa, M., Morelli, M., Mantovani, F., Guida, E., Piazza, S., Collavin, L., Brancolini, C., Schneider, C., and Del Sal, G. (2004) The transcriptional repressor hDaxx potentiates p53-dependent apoptosis. J. Biol. Chem. 279, 48013-48023 (Pubitemid 39540954)
29. Zhang, X., Gu, L., Li, J., Shah, N., He, J., Yang, L., Hu, Q., and Zhou, M. (2010) Degradation of MDM2 by the interaction between berberine and DAXX leads to potent apoptosis in MDM2-overexpressing cancer cells. Cancer Res. 70, 9895-9904
30. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. (1991) p53 mutations in human cancers. Science 253, 49-53 (Pubitemid 21917115)
31. Haupt, Y., Maya, R., Kazaz, A., and Oren, M. (1997) Mdm2 promotes the rapid degradation of p53. Nature 387, 296-299 (Pubitemid 27220766)
32. Zhou, M., Gu, L., Abshire, T. C., Homans, A., Billett, A. L., Yeager, A. M., and Findley, H. W. (2000) Incidence and prognostic significance of MDM2 oncoprotein overexpression in relapsed childhood acute lymphoblastic leukemia. Leukemia 14, 61-67 (Pubitemid 30068374)
33. Thaler, S., Hahnel, P. S., Schad, A., Dammann, R., and Schuler, M. (2009) RASSF1A mediates p21Cip1/Waf1-dependent cell cycle arrest and senescence through modulation of the Raf-MEK-ERK pathway and inhibition of Akt. Cancer Res. 69, 1748-1757
34. Shivakumar, L., Minna, J., Sakamaki, T., Pestell, R., and White, M. A. (2002) The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol. Cell. Biol. 22, 4309-4318 (Pubitemid 34556598)
35. Whang, Y. M., Kim, Y. H., Kim, J. S., and Yoo, Y. D. (2005) RASSF1A suppresses the c-Jun-NH2-kinase pathway and inhibits cell cycle progression. Cancer Res. 65, 3682-3690 (Pubitemid 40616345)
36. Oh, H. J., Lee, K. K., Song, S. J., Jin, M. S., Song, M. S., Lee, J. H., Im, C. R., Lee, J. O., Yonehara, S., and Lim, D. S. (2006) Role of the tumor suppressor RASSF1A in Mst1-mediated apoptosis. Cancer Res. 66, 2562-2569
37. Rabizadeh, S., Xavier, R. J., Ishiguro, K., Bernabeortiz, J., Lopez-Ilasaca, M., Khokhlatchev, A., Mollahan, P., Pfeifer, G. P., Avruch, J., and Seed, B. (2004) The scaffold protein CNK1 interacts with the tumor suppressor RASSF1A and augments RASSF1A-induced cell death. J. Biol. Chem. 279, 29247-29254 (Pubitemid 38915800)
38. Preudhomme, C., Dervite, I., Wattel, E., Vanrumbeke, M., Flactif, M., Lai, J. L., Hecquet, B., Coppin, M. C., Nelken, B., and Gosselin, B. (1995) Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: a report of 48 cases. J. Clin. Oncol. 13, 812-820
39. King, T. C., Akerley, W., Fan, A. C., Moore, T., Mangray, S., Hsiu Chen, M., and Safran, H. (2000) p53 mutations do not predict response to paclitaxel in metastatic nonsmall cell lung carcinoma. Cancer 89, 769-773 (Pubitemid 30658575)
40. Michaelson, J. S., Bader, D., Kuo, F., Kozak, C., and Leder, P. (1999) Loss of Daxx, a promiscuously interacting protein, results in extensive apoptosis in early mouse development. Genes Dev. 13, 1918-1923 (Pubitemid 29407359)
41. Michaelson, J. S., and Leder, P. (2003) RNAi reveals antiapoptotic and transcriptionally repressive activities of DAXX. J. Cell Sci. 116, 345-352 (Pubitemid 36163875)
42. Chen, L. Y., and Chen, J. D. (2003) Daxx silencing sensitizes cells to multiple apoptotic pathways. Mol. Cell. Biol. 23, 7108-7121
43. Jiao, Y., Shi, C., Edil, B. H., de Wilde, R. F., Klimstra, D. S., Maitra, A., Schulick, R. D., Tang, L. H., Wolfgang, C. L., Choti, M. A., Velculescu, V. E., Diaz, L. A., Jr., Vogelstein, B., Kinzler, K. W., Hruban, R. H., and Papadopoulos, N. (2011) DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science 331, 1199-1203